Yingbiao Ji
Research Subjects
Yingbiao Ji has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alexei V. Tulin
Fox Chase Cancer Center, Philadelphia, PA 19111
1 shared publication - Biwei Zhao
Frontage Laboratories, Exton, USA
1 shared publication - Bonnie Wu
Johnson & Johnson Innovative Medicine, Spring House, PA, USA
1 shared publication Colin Thomas
Fox Chase Cancer Center, Philadelphia, PA 19111
1 shared publicationErnest Boamah
Fox Chase Cancer Center, Philadelphia, PA 19111
1 shared publication- James Devlin
Johnson & Johnson Innovative Medicine, Spring House, PA, USA
1 shared publication
Latest Publications
- 17 December 2025
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (1) , 37
Implementing Synthetic Multi-Transmembrane Receptor Protein in a Duplex Immunoassay for Assessment of Neutralizing Antibody to a Bispecific Biotherapeutic
The development of multi-specific biotherapeutics has revolutionized targeted therapy by simultaneously engaging multiple receptors or pathways, thereby en
- 17 December 2025
- Published by Springer Nature in The AAPS Journal
- Vol. 28 (1) , 37
Implementing Synthetic Multi-Transmembrane Receptor Protein in a Duplex Immunoassay for Assessment of Neutralizing Antibody to a Bispecific Biotherapeutic
The development of multi-specific biotherapeutics has revolutionized targeted therapy by simultaneously engaging multiple receptors or pathways, thereby en
- 15 September 2016
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 197 (6) , 2382-2389
Charon Mediates Immune Deficiency–Driven PARP-1–Dependent Immune Responses in Drosophila
Regulation of NF-κB nuclear translocation and stability is central to mounting an effective innate immune response. In this article, we describe a novel molecular mechanism controlling NF-κB–dependent innate immune response. We show that a previously unknown protein, termed as Charon, functions as a regulator of antibacterial and antifungal immune defense in Drosophila. Charon is an ankyrin repeat–containing protein that mediates poly(ADP-ribose) polymerase-1 (PARP-1)–dependent transcriptional responses downstream of the innate immune pathway. Our results demonstrate that Charon interacts with the NF-κB ortholog Relish inside perinuclear particles and delivers active Relish to PARP-1–bearing promoters, thus triggering NF-κB/PARP-1–dependent transcription of antimicrobial peptides. Ablating the expression of Charon prevents Relish from targeting promoters of antimicrobial genes and effectively suppresses the innate immune transcriptional response. Taken together, these results implicate Charon as an essential mediator of PARP-1–dependent transcription in the innate immune pathway. Thus, to our knowledge, our results are the first to describe the molecular mechanism regulating translocation of the NF-κB subunit from cytoplasm to chromatin.
- 15 September 2016
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 197 (6) , 2382-2389
Charon Mediates Immune Deficiency–Driven PARP-1–Dependent Immune Responses in Drosophila
Regulation of NF-κB nuclear translocation and stability is central to mounting an effective innate immune response. In this article, we describe a novel molecular mechanism controlling NF-κB–dependent innate immune response. We show that a previously unknown protein, termed as Charon, functions as a regulator of antibacterial and antifungal immune defense in Drosophila. Charon is an ankyrin repeat–containing protein that mediates poly(ADP-ribose) polymerase-1 (PARP-1)–dependent transcriptional responses downstream of the innate immune pathway. Our results demonstrate that Charon interacts with the NF-κB ortholog Relish inside perinuclear particles and delivers active Relish to PARP-1–bearing promoters, thus triggering NF-κB/PARP-1–dependent transcription of antimicrobial peptides. Ablating the expression of Charon prevents Relish from targeting promoters of antimicrobial genes and effectively suppresses the innate immune transcriptional response. Taken together, these results implicate Charon as an essential mediator of PARP-1–dependent transcription in the innate immune pathway. Thus, to our knowledge, our results are the first to describe the molecular mechanism regulating translocation of the NF-κB subunit from cytoplasm to chromatin.